$RCEL AVITA Medical, Inc. Insider Trading
Get free email notifications about insider trading in AVITA Medical, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AVITA Medical, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in AVITA Medical, Inc. for free.
CIK Number: 0001762303
IRS Number: 202578762
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: RCEL
Company Address: 28159 AVENUE STANFORD SUITE 220 VALENCIA 91355
Phone number: 833-462-8482
Former name: Avita Medical, Ltd., date of change: 2018-12-18
Former name: Avita Therapeutics, Inc., date of change: 2020-06-30
AVITA Medical, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | RCEL | AVITA Medical, Inc ... | Holder Michael | Chief Financial Off ... | Option Exercise | A | 19.91 | 112,500 | 2,239,875 | 112,500 | |
Mar 25 2021 | RCEL | AVITA Medical, Inc ... | Holder Michael | Chief Financial Off ... | Option Exercise | A | 22.25 | 37,500 | 834,375 | 37,500 | |
Mar 19 2021 | RCEL | AVITA Medical, Inc ... | Ekins Sean | Sr. VP of Finance | Option Exercise | A | 21.93 | 30,000 | 657,900 | 30,000 | |
Dec 16 2020 | RCEL | AVITA Medical, Inc ... | Ekins Sean | Sr. VP of Finance | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 27.41 | 9,000 | 246,690 | 425,087 | 434.1 K to 425.1 K (-2.07 %) |
Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 27.23 | 23,769 | 647,230 | 434,087 | 457.9 K to 434.1 K (-5.19 %) |
Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.99 | 15,092 | 407,333 | 457,856 | 472.9 K to 457.9 K (-3.19 %) |
Sep 16 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 68,504 | 0 | 472,948 | 404.4 K to 472.9 K (+16.94 %) |
Sep 11 2020 | RCEL | Avita Therapeutics ... | Shiroma Donna | General Counsel | Option Exercise | A | 4.38 | 4,400 | 19,272 | 8,600 | |
Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Option Exercise | A | 5.99 | 25,000 | 149,750 | 150,000 | |
Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.02 | 20,000 | 520,400 | 404,444 | 424.4 K to 404.4 K (-4.71 %) |
Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Sell | S | 26.26 | 7,128 | 187,181 | 424,444 | 431.6 K to 424.4 K (-1.65 %) |
Sep 11 2020 | RCEL | Avita Therapeutics ... | PERRY MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 83,333 | 0 | 431,572 | 348.2 K to 431.6 K (+23.93 %) |
Sep 11 2020 | RCEL | Avita Therapeutics ... | Liberto Erin | Chief Commercial Of ... | Option Exercise | A | 5.03 | 6,000 | 30,180 | 24,000 | |
Sep 11 2020 | RCEL | Avita Therapeutics ... | Quick Andrew | Chief Technology Of ... | Option Exercise | A | 6.32 | 4,038 | 25,520 | 16,150 |